Borderline multicystic peritoneal mesothelioma

Our plain-English summary of Borderline multicystic peritoneal mesothelioma, by S. Landolsi, A. Bouchrika, M. Debaibi, et al (Surgery, 2022).

The study

• Authors: S. Landolsi, A. Bouchrika, M. Debaibi, I. Ridène, F. Chebbi
• Journal: Surgery
• Published: 2022;171(2):e5-e6
• Type of article: Case report
• Cited by: 1 article, as counted by NIH iCite
• Read it: PubMed · Publisher

In plain English

This was a short case report in the journal's "Images in Surgery" quiz format. It described one patient; the authors worked at Mahmoud El Matri Hospital in Ariana, Tunisia. The patient was a 45-year-old woman with no medical history apart from two operations, in 2009 and 2010, for a hemorrhagic ovarian cyst. Tissue examination after those operations found benign lesions. Five months before the report, she developed pain in the right upper abdomen. Computed tomography and magnetic resonance imaging scans showed cystic lesions, especially in the pelvis. An exploratory laparoscopy found multiple cystic lesions throughout the peritoneal cavity (the space inside the abdomen). The authors gave the diagnosis as borderline multicystic peritoneal mesothelioma. Citing other publications, they described this as a rare tumor with a high risk of returning after debulking surgery. They wrote that this risk has led to proposals of cytoreduction combined with heated chemotherapy delivered into the abdomen. The report did not mention asbestos or any other exposure. It did not say how the diagnosis was confirmed, how this patient was treated, or what happened to her.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: case report (single patient, presented as an image quiz)
• Who was studied: One 45-year-old woman, reported by authors at Mahmoud El Matri Hospital, Ariana, Tunisia. She had two earlier surgeries (2009 and 2010) for hemorrhagic ovarian cyst, which the authors place in their gynecologic department.
• Exposure: No asbestos or other exposure is reported in the article
• Main results:
  • The patient had two earlier operations for hemorrhagic ovarian cyst, in 2009 and 2010, and tissue examination found benign lesions
  • She presented with right upper abdominal pain that began 5 months earlier
  • CT and MRI showed cystic lesions in the pelvis
  • Exploratory laparoscopy showed multiple cystic lesions throughout the peritoneal cavity
  • The diagnosis given was borderline multicystic peritoneal mesothelioma
• The authors' conclusion: Citing other publications, the authors stated that borderline multicystic peritoneal mesothelioma is a rare tumor. They wrote that its high risk of recurrence after debulking resection has led to proposals of cytoreduction with hyperthermic intraperitoneal chemotherapy.

Topics

Medical terms in this study, explained in our Lexicon: Peritoneal Mesothelioma.

Related studies

• Benign Multicystic Peritoneal Mesothelioma: AIRP Best Cases in Radiologic-Pathologic Correlation — R. Lee, A. Tong, et al. (2016)
• Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma — F. Mercier, G. Jeremie, et al. (2020)
• Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy — E. Nizri, D. Baratti, et al. (2018)
• Multicystic peritoneal mesothelioma: A short review — C.H. Zhang, J.W. Yu, et al. (2017)
• Benign cystic peritoneal mesothelioma incorrectly diagnosed as an ovarian borderline mucinous tumor of intestinal type at transvaginal preoperative ultrasound evaluation — A.C. Testa, G.F. Zannoni, et al. (2011)
• Imaging appearance of benign multicystic peritoneal mesothelioma: a case report and review of the literature — V. Mehta, V. Chowdhary, et al. (2017)

Browse more research in Surgery, or return to medical research.